FDA Approved: METRONIDAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for metronidazole (ANDA070027), authorizing changes to the approved product through a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amebiasis
• Anaerobic Bacterial Infections
• Bacterial Vaginosis
• Giardiasis
• Gynecologic Infections
• Intra-abdominal Infections
• Rosacea
• Trichomoniasis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

SUPPL AP for METRONIDAZOLE (METRONIDAZOLE)